Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
End-Stress: Endothelin Receptor Function and Acute Stress
NCT02116335Active, not recruiting
- Sponsor
- Augusta University
- Start
- Jun 2015
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in hypertension (HTN) comparing Bosentan with Placebo (2 arms). Primary endpoint: Flow-Mediated Dilation at 3 days. Started Jun 2015; status: active, not recruiting.
02
Drugs
bosentan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02116335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116335.